Search Results 1401-1410 of 20474 for hepatitis

  1. A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma - Mayo Clinic

    -Radiotherapy within 7 days of the start of study therapy. -CART infusion within 30 days prior to Day 1 of Cycle 1 -Active hepatitis B or C, as defined below: - ...

  2. Cyclophosphamide, Ixazomib, and Dexamethasone in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

    Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection; Any serious medical or psychiatric illness that could ...

  3. Making a donation - Mayo Clinic

    The potential donor had an infectious or contagious disease, such as HIV/AIDS, hepatitis B, hepatitis C, tuberculosis or prion diseases. The next of kin ...

  4. fecal microbiota transplant Archives - Mayo Clinic News Network

    ... Hepatitis C. Imagine a gut bacteria so strong that it resists antibiotic treatment. Clostridium difficile (C-diff) can be difficult to treat, but a new ...

  5. Transplant

    Transmission Of Hepatitis C Infection To Patients. Dana Sparks. April 6, 2012. Growing Organs From Patient's Own Stem Cells (pkg). Dana Sparks. March 27, 2012.

  6. Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer - Mayo Clinic

    * Is known to be positive for Hepatitis B virus (HBV) or Hepatitis C virus (HCV). Participants are eligible if they have a history of HCV infection that has ...

  7. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

    ... hepatitis B will be excluded unless the following criteria can be met: - If patient's serology shows hepatitis B virus core antibody (HbcAb)+ and hepatitis ...

  8. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

    Has known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV RNA [qualitative] is detected). Has received a live vaccine or live-attenuated ...

  9. A Study to Evaluate the Effectiveness and Safety of Virtual Reality in the Treatment of Functional Dyspepsia - Mayo Clinic

    Patients will be excluded from the study if symptoms are thought to represent an organic disorder (e.g., peptic ulcer disease, hepatitis, pancreatitis ...

  10. Deb Balzer | Mayo Clinic News Network - Page 49 of 69

    Infectious Diseases A-Z: Increasing hepatitis infections. Hepatitis, a disease characterized by inflammation of the liver, affects millions of Americans.